Cargando…

Correction: Image guided dose escalated prostate radiotherapy: still room to improve

We regret to report that a proofreading error caused an incorrect legend and description of the contents of table 6 to appear in our original publication of this work. The correct description of table 6 is: Univariate analysis of prognostic factors for 5-year nadir + 2 biochemical outcome for men pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martin, Jarad M, Bayley, Andrew, Bristow, Robert, Chung, Peter, Gospodarowicz, Mary, Menard, Cynthia, Milosevic, Michael, Rosewall, Tara, Warde, Padraig R, Catton, Charles N
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2800112/ http://dx.doi.org/10.1186/1748-717X-4-65

Ejemplares similares

Image guided dose escalated prostate radiotherapy: still room to improve
por: Martin, Jarad M, et al.
Publicado: (2009)

The effect of bowel preparation regime on interfraction rectal filling variation during image guided radiotherapy for prostate cancer
por: Hosni, Ali, et al.
Publicado: (2017)

Dosimetric comparison of MR-guided adaptive IMRT versus 3DOF-VMAT for prostate stereotactic radiotherapy
por: Kong, Vickie C., et al.
Publicado: (2022)

[(18)F]DCFPyL PET-MRI/CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: study protocol for a phase II trial
por: Glicksman, Rachel M, et al.
Publicado: (2020)

Impact of intrafraction changes in delivered dose of the day for prostate cancer patients treated with stereotactic body radiotherapy via MR-Linac
por: Dang, Jennifer, et al.
Publicado: (2022)

MRI-guided Dose-escalated Salvage Radiotherapy for Bulky Bladder Neck Recurrence of Prostate Cancer
por: Kishan, Amar U, et al.
Publicado: (2018)

The dosimetric underpinning of bladder filling criteria for prostate image-guided volumetric modulated arc therapy
por: Kong, Vickie, et al.
Publicado: (2023)

Patterns of practice of adaptive re-planning for anatomic variances during cone-beam CT guided radiotherapy
por: Stankiewicz, Michal, et al.
Publicado: (2019)

Toxicity of dose-escalated radiotherapy up to 84 Gy for prostate cancer
por: Rosenbrock, Johannes, et al.
Publicado: (2023)

Potential Applications of Image-Guided Radiotherapy for Radiation Dose Escalation in Patients with Early Stage High-Risk Prostate Cancer
por: Nguyen, Nam P., et al.
Publicado: (2015)

Neural network dose prediction for rectal spacer stratification in dose‐escalated prostate radiotherapy
por: Thomas, Christopher, et al.
Publicado: (2022)

Long-Term Outcomes of Dose-Escalated Hypofractionated Radiotherapy in Localized Prostate Cancer
por: Lazo, Antonio, et al.
Publicado: (2022)

FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancer
por: Thureau, Sébastien, et al.
Publicado: (2018)

Online MR guided dose escalated radiotherapy for organ preservation in distal rectal cancer
por: Boeke, Simon, et al.
Publicado: (2022)

Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma
por: Elganainy, Dalia, et al.
Publicado: (2018)

Global Access to Radiotherapy—Work in Progress
por: Gospodarowicz, Mary
Publicado: (2021)

Breast Cancer Screening: Is There Room for De-escalation?
por: Kim, Leah S., et al.
Publicado: (2022)

Efficacy of Dose-Escalated Radiotherapy for Recurrent Colorectal Cancer
por: Jo, Sunmi, et al.
Publicado: (2016)

Dose-Escalated Hypofractionated Intensity-Modulated Radiotherapy in High-Risk Carcinoma of the Prostate: Outcome and Late Toxicity
por: Thomson, David, et al.
Publicado: (2012)

Feasibility and Outcome of PSMA-PET-Based Dose-Escalated Salvage Radiotherapy Versus Conventional Salvage Radiotherapy for Patients With Recurrent Prostate Cancer
por: Vogel, Marco M. E., et al.
Publicado: (2021)

Salvage low-dose-rate (125)I partial prostate brachytherapy after dose-escalated external beam radiotherapy
por: Chang, Lynn, et al.
Publicado: (2014)

Plasma osteopontin as a biomarker of prostate cancer aggression: relationship to risk category and treatment response
por: Thoms, J W, et al.
Publicado: (2012)

To escalate thromboprophylacic heparin intensity in COVID‐19 or not? That is still the question
por: Bikdeli, Behnood
Publicado: (2022)

Randomised pilot study of dose escalation using conformal radiotherapy in prostate cancer: long-term follow-up
por: Creak, A, et al.
Publicado: (2013)

Dose escalation of external beam radiotherapy for high-risk prostate cancer—Impact of multiple high-risk factor
por: Umezawa, Rei, et al.
Publicado: (2019)

Impact of androgen-deprivation therapy on the outcome of dose-escalation prostate cancer radiotherapy without elective pelvic irradiation
por: Hou, Wei-Hsien, et al.
Publicado: (2017)

Phase I dose escalation trial of stereotactic radiotherapy prior to robotic prostatectomy in high risk prostate cancer
por: Liveringhouse, Casey, et al.
Publicado: (2021)

Dose escalated intensity modulated radiotherapy in the treatment of cervical cancer
por: Cihoric, Nikola, et al.
Publicado: (2015)

Dose-Escalated Radiotherapy for the Treatment of Patients With Recurrent Colorectal Cancer
por: Kim, Hyung Jin, et al.
Publicado: (2016)

The in-silico feasibility of dose escalated, hypofractionated radiotherapy for rectal cancer
por: Devlin, Lynsey, et al.
Publicado: (2022)

Long-term outcomes from dose-escalated image-guided intensity-modulated radiotherapy with androgen deprivation: encouraging results for intermediate- and high-risk prostate cancer
por: Wilcox, Shea W, et al.
Publicado: (2014)

Dose-Escalated Salvage Radiotherapy for Macroscopic Local Recurrence of Prostate Cancer in the Prostate-Specific Membrane Antigen Positron Emission Tomography Era
por: Tamihardja, Jörg, et al.
Publicado: (2022)

Is There Still Room for Novelty, in Histochemical Papers?
por: Pellicciari, C.
Publicado: (2016)

Dose differentiated high-dose-rate prostate brachytherapy: a feasibility assessment of MRI-guided dose escalation to dominant intra-prostatic lesions
por: Luminais, Christopher K., et al.
Publicado: (2022)

Visualising the urethra for prostate radiotherapy planning
por: Richardson, Matthew, et al.
Publicado: (2021)

Estimating the Impact of Randomised Control Trial Results on Clinical Practice: Results from a Survey and Modelling Study of Androgen Deprivation Therapy plus Radiotherapy for Locally Advanced Prostate Cancer
por: South, Annabelle, et al.
Publicado: (2016)

NBN gain is predictive for adverse outcome following image-guided radiotherapy for localized prostate cancer
por: Berlin, Alejandro, et al.
Publicado: (2014)

Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects
por: Dearnaley, D P, et al.
Publicado: (2005)

Regional hyperthermia and moderately dose-escalated salvage radiotherapy for recurrent prostate cancer. Protocol of a phase II trial
por: Müller, Arndt-Christian, et al.
Publicado: (2015)

Impact of Dose Escalation on the Efficacy of Salvage Radiotherapy for Recurrent Prostate Cancer—A Risk-Adjusted, Matched-Pair Analysis
por: Böhmer, Dirk, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dl5mues3uectramkjemn9fauq8